(Q40661233)

English

Improved effect of an antiangiogenic tyrosine kinase inhibitor (SU5416) by combinations with fractionated radiotherapy or low molecular weight heparin

scientific article published on March 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Improved effect of an antiangiogenic tyrosine kinase inhibitor (SU5416) by combinations with fractionated radiotherapy or low molecular weight heparin (English)

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

author name string

Eva L Lund

1

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Minna W B Olsen

2

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Kenneth E Lipson

3

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Gerald McMahon

4

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Anthony R Howlett

5

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

Paul E G Kristjansen

6

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

155-160

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Low-molecular-weight heparin and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Angiogenesis in cancer and other diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Openings between defective endothelial cells explain tumor vessel leakiness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

22 September 2017

Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

25 September 2017

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

25 September 2017

Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

25 September 2017

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

15 June 2018

In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

15 June 2018

Pathophysiology of human tumor xenografts. Aspects of metabolism, physiology, and pharmacokinetics in heterotransplanted human lung and colon tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

15 June 2018

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

15 June 2018

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

15 June 2018

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Cancer. What does radiotherapy do to endothelial cells?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1502401

19 August 2018

Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12659688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12659688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12659688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12659688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1476-5586(03)80007-6

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40661233&oldid=1504097560"